Pfizer Limited (PFIZER) - Total Liabilities
Based on the latest financial reports, Pfizer Limited (PFIZER) has total liabilities worth Rs7.57 Billion INR (≈ $81.89 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PFIZER cash flow metrics to assess how effectively this company generates cash.
Pfizer Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Pfizer Limited's total liabilities have evolved over time, based on quarterly financial data. Check PFIZER asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Pfizer Limited Competitors by Total Liabilities
The table below lists competitors of Pfizer Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BaoJi Titanium Industry Co Ltd
SHG:600456
|
China | CN¥7.45 Billion |
|
Isrotel -L
TA:ISRO
|
Israel | ILA2.62 Billion |
|
Tiger Brands Ltd
JSE:TBS
|
South Africa | ZAC9.72 Billion |
|
Paz Oil
TA:PZOL
|
Israel | ILA7.69 Billion |
|
Sendas Distribuidora S.A.
SA:ASAI3
|
Brazil | R$46.05 Billion |
|
Shanghai Beite Technology Co
SHG:603009
|
China | CN¥1.87 Billion |
|
Lien Hwa Industrial Corp
TW:1229
|
Taiwan | NT$17.81 Billion |
|
Tokai Carbon Korea Co. Ltd
KQ:064760
|
Korea | ₩40.75 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Pfizer Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PFIZER stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 4.19 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pfizer Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pfizer Limited (2005–2025)
The table below shows the annual total liabilities of Pfizer Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs6.94 Billion ≈ $75.02 Million |
+9.55% |
| 2024-03-31 | Rs6.33 Billion ≈ $68.48 Million |
-20.19% |
| 2023-03-31 | Rs7.93 Billion ≈ $85.81 Million |
-23.42% |
| 2022-03-31 | Rs10.36 Billion ≈ $112.05 Million |
+18.70% |
| 2021-03-31 | Rs8.73 Billion ≈ $94.40 Million |
-13.57% |
| 2020-03-31 | Rs10.10 Billion ≈ $109.22 Million |
+8.75% |
| 2019-03-31 | Rs9.29 Billion ≈ $100.43 Million |
-7.76% |
| 2018-03-31 | Rs10.07 Billion ≈ $108.88 Million |
+18.20% |
| 2017-03-31 | Rs8.52 Billion ≈ $92.11 Million |
+7.04% |
| 2016-03-31 | Rs7.96 Billion ≈ $86.05 Million |
+24.62% |
| 2015-03-31 | Rs6.39 Billion ≈ $69.06 Million |
+140.11% |
| 2014-03-31 | Rs2.66 Billion ≈ $28.76 Million |
-27.16% |
| 2013-03-31 | Rs3.65 Billion ≈ $39.48 Million |
+34.34% |
| 2012-03-31 | Rs2.72 Billion ≈ $29.39 Million |
+21.97% |
| 2011-03-31 | Rs2.23 Billion ≈ $24.10 Million |
+6.59% |
| 2010-03-31 | Rs2.09 Billion ≈ $22.61 Million |
+6.35% |
| 2009-03-31 | Rs1.97 Billion ≈ $21.26 Million |
-9.73% |
| 2008-03-31 | Rs2.18 Billion ≈ $23.55 Million |
+5.32% |
| 2007-03-31 | Rs2.07 Billion ≈ $22.36 Million |
+3.32% |
| 2006-03-31 | Rs2.00 Billion ≈ $21.64 Million |
+9.56% |
| 2005-03-31 | Rs1.83 Billion ≈ $19.75 Million |
-- |
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vi… Read more